Group One Trading
LXRX icon

Group One Trading’s Lexicon Pharmaceuticals LXRX Stock Holding History

Group One Trading’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.2K Sell
10,400
-14,700
-59% -$21.4K ﹤0.01% 6093
2025
Q4 		$28.9K Sell
25,100
-100
-0.4% -$137 ﹤0.01% 6054
2025
Q3 		$34K Buy
25,200
+9,600
+62% +$10.9K ﹤0.01% 6264
2025
Q2 		$14.8K Sell
15,600
-15,700
-50% -$10.2K ﹤0.01% 6465
2025
Q1 		$14.4K Sell
31,300
-8,300
-21% -$5.24K ﹤0.01% 6029
2024
Q4 		$29.2K Sell
39,600
-3,400
-8% -$4.1K ﹤0.01% 5449
2024
Q3 		$67.5K Buy
43,000
+10,600
+33% +$18.9K ﹤0.01% 4449
2024
Q2 		$54.4K Sell
32,400
-11,600
-26% -$20.8K ﹤0.01% 4470
2024
Q1 		$106K Buy
44,000
+1,600
+4% +$3.44K ﹤0.01% 4108
2023
Q4 		$64.9K Sell
42,400
-7,800
-16% -$9.27K ﹤0.01% 4846
2023
Q3 		$54.7K Sell
50,200
-127,200
-72% -$223K ﹤0.01% 5013
2023
Q2 		$406K Buy
177,400
+171,200
+2,761% +$454K ﹤0.01% 3223
2023
Q1 		$15.1K Buy
6,200
+5,600
+933% +$12.8K ﹤0.01% 5702
2022
Q4 		$1.15K Sell
600
-800
-57% -$1.7K ﹤0.01% 6798
2022
Q3 		$3K Sell
1,400
-23,700
-94% -$65.6K ﹤0.01% 7026
2022
Q2 		$47K Buy
25,100
+24,800
+8,267% +$47.3K ﹤0.01% 5615
2022
Q1 		$1K Sell
300
-17,900
-98% -$49.6K ﹤0.01% 7843
2021
Q4 		$72K Sell
18,200
-16,500
-48% -$80.1K ﹤0.01% 6028
2021
Q3 		$167K Buy
34,700
+22,400
+182% +$91.9K ﹤0.01% 5356
2021
Q2 		$56K Sell
12,300
-28,600
-70% -$138K ﹤0.01% 6472
2021
Q1 		$240K Buy
40,900
+3,200
+8% +$22.2K ﹤0.01% 4834
2020
Q4 		$129K Buy
37,700
+33,700
+843% +$64.3K ﹤0.01% 4381
2020
Q3 		$6K Sell
4,000
-8,300
-67% -$14.8K ﹤0.01% 5581
2020
Q2 		$25K Sell
12,300
-14,700
-54% -$28.8K ﹤0.01% 4723
2020
Q1 		$53K Buy
27,000
+300
+1% +$893 ﹤0.01% 3672
2019
Q4 		$111K Sell
26,700
-53,400
-67% -$206K ﹤0.01% 3576
2019
Q3 		$241K Buy
80,100
+71,100
+790% +$220K ﹤0.01% 2947
2019
Q2 		$57K Sell
9,000
-7,500
-45% -$44.9K ﹤0.01% 3701
2019
Q1 		$92K Sell
16,500
-10,500
-39% -$63.8K ﹤0.01% 3232
2018
Q4 		$179K Hold
27,000
– – ﹤0.01% 2769
2018
Q3 		$288K Buy
27,000
+25,000
+1,250% +$286K ﹤0.01% 2740
2018
Q2 		$24K Buy
+2,000
New +$20.5K ﹤0.01% 4306
2017
Q4 		– Sell
-97,600
Closed -$1.2M – 5049
2017
Q3 		$1.2M Buy
97,600
+90,200
+1,219% +$1.33M 0.01% 1425
2017
Q2 		$122K Sell
7,400
-4,500
-38% -$69.7K ﹤0.01% 2992
2017
Q1 		$171K Sell
11,900
-33,700
-74% -$500K ﹤0.01% 2632
2016
Q4 		$631K Buy
45,600
+39,600
+660% +$635K 0.01% 1630
2016
Q3 		$108K Sell
6,000
-17,800
-75% -$286K ﹤0.01% 2879
2016
Q2 		$342K Buy
23,800
+17,600
+284% +$239K ﹤0.01% 2014
2016
Q1 		$74K Sell
6,200
-7,800
-56% -$81.8K ﹤0.01% 3021
2015
Q4 		$186K Sell
14,000
-14,700
-51% -$181K ﹤0.01% 2544
2015
Q3 		$308K Buy
28,700
+26,700
+1,335% +$292K ﹤0.01% 2180
2015
Q2 		$16K Buy
+2,000
New +$14.7K ﹤0.01% 4135

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Group One Trading's LXRX Position: Q1 2026 in Review

Group One Trading reduced its Lexicon Pharmaceuticals (LXRX) stake by 18% in Q1 2026, selling an estimated $57.1K and leaving 185,006 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #3829.

Group One Trading first reported a position in LXRX in Q3 2015 and has held it in 28 quarters since. The position peaked at $861K in Q3 2017. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Group One Trading held 185,006 shares of Lexicon Pharmaceuticals worth $289K as of Q1 2026.
  • Group One Trading sold 39,302 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $57.1K.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3829 holding.
  • Group One Trading first reported a position in Lexicon Pharmaceuticals in Q3 2015 and has held it in 28 quarters since.
  • Group One Trading's Lexicon Pharmaceuticals position peaked at $861K in Q3 2017.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.